Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine: a Naturalistic, Prospective, Multicentric Observational Study of 6 Months Follow-up

NCT00952757 is registered in ClinicalTrials.gov with Investigaciones Médicas Montejo S.L. as lead sponsor.

NCT NCT00952757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine: a Naturalistic, Prospective, Multicentric Observational Study of 6 Months Follow-up
Lead sponsor
Investigaciones Médicas Montejo S.L.
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
August 31, 2008
Enrollment
35 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aps-related hyperprolactinaemia, bipolar disorder, schizophrenia